Connection

Edward Hogan to Rats

Back to Details
This is a "connection" page, showing publications Edward Hogan has written about Rats.
Edward Hogan
Connection Strength
0.615
Rats
  1. Novel myelin penta- and hexa-acetyl-galactosyl-ceramides: structural characterization and immunoreactivity in cerebrospinal fluid. J Lipid Res. 2010 Jun; 51(6):1394-406.
    View in: PubMed
    Score: 0.047
  2. Treatment of spinal cord impact injury in the rat with transforming growth factor-beta. J Neurol Sci. 2002 Aug 15; 200(1-2):33-41.
    View in: PubMed
    Score: 0.028
  3. Inhibition of proteolysis by a cyclooxygenase inhibitor, indomethacin. Neurochem Res. 2000 Nov; 25(11):1509-15.
    View in: PubMed
    Score: 0.025
  4. Molecular characterization and immunohistochemical localization of IV(4)GalNAcGgOse(4)Cer: a naturally occurring novel neutral glycosphingolipid in bovine brain. Glycobiology. 2000 Jan; 10(1):1-9.
    View in: PubMed
    Score: 0.023
  5. Immunohistochemical localization of kininogen in rat spinal cord and brain. Exp Neurol. 1999 Oct; 159(2):528-37.
    View in: PubMed
    Score: 0.023
  6. Extracellular signal-regulated kinase and p38 subgroups of mitogen-activated protein kinases regulate inducible nitric oxide synthase and tumor necrosis factor-alpha gene expression in endotoxin-stimulated primary glial cultures. J Neurosci. 1998 Mar 01; 18(5):1633-41.
    View in: PubMed
    Score: 0.021
  7. Increased calpain content and progressive degradation of neurofilament protein in spinal cord injury. Brain Res. 1997 Mar 28; 752(1-2):301-6.
    View in: PubMed
    Score: 0.019
  8. A new mechanism of methylprednisolone and other corticosteroids action demonstrated in vitro: inhibition of a proteinase (calpain) prevents myelin and cytoskeletal protein degradation. Brain Res. 1997 Feb 14; 748(1-2):205-10.
    View in: PubMed
    Score: 0.019
  9. Developmental and topographic expression of neutral glycosphingolipids in vertebrate brain. Indian J Biochem Biophys. 1997 Feb-Apr; 34(1-2):166-9.
    View in: PubMed
    Score: 0.019
  10. Neutral monoglycosylceramides in rat brain: occurrence, molecular expression and developmental variation. Dev Neurosci. 1997; 19(2):152-61.
    View in: PubMed
    Score: 0.019
  11. Neuron-microglia interaction induced bi-directional cytotoxicity associated with calpain activation. J Neurochem. 2016 11; 139(3):440-455.
    View in: PubMed
    Score: 0.019
  12. Thrombin activates mitogen-activated protein kinase in primary astrocyte cultures. J Cell Physiol. 1995 Nov; 165(2):417-24.
    View in: PubMed
    Score: 0.017
  13. Molecular characterization of gangliotetraosylceramide (GA1) in normal human brain and its developmental change. Indian J Biochem Biophys. 1993 Dec; 30(6):341-5.
    View in: PubMed
    Score: 0.015
  14. Effects of fish oil supplementation on acute ischemic brain injury in the rat. Neurology. 1993 Jun; 43(6):1227-32.
    View in: PubMed
    Score: 0.015
  15. Calcium-activated neutral proteinase (calpain) in rat brain during development: compartmentation and role in myelination. Brain Res Dev Brain Res. 1993 Jan 15; 71(1):107-13.
    View in: PubMed
    Score: 0.014
  16. Effects of detergents on Ca(2+)-activated neural proteinase activity (calpain) in neural and non-neural tissue: a comparative study. Neurochem Res. 1992 Aug; 17(8):797-802.
    View in: PubMed
    Score: 0.014
  17. Calcium-activated neutral proteinase (calpain) activity in C6 cell line: compartmentation of mu and m calpain. J Neurosci Res. 1992 Apr; 31(4):708-14.
    View in: PubMed
    Score: 0.014
  18. Effect of plasma glucose on infarct size in focal cerebral ischemia-reperfusion. Neurology. 1991 Jun; 41(6):899-905.
    View in: PubMed
    Score: 0.013
  19. A sensitive fluorometric method for measurement of vascular permeability in spinal cord injury. J Neurotrauma. 1991; 8(2):149-56.
    View in: PubMed
    Score: 0.012
  20. Glycosphingolipid biosynthesis during myogenesis of rat L6 cells in vitro. Mol Cell Biochem. 1988 Sep; 83(1):47-54.
    View in: PubMed
    Score: 0.011
  21. Ca2+-mediated degradation of central nervous system (CNS) proteins: topographic and species variation. Metab Brain Dis. 1987 Jun; 2(2):117-26.
    View in: PubMed
    Score: 0.010
  22. A model of focal ischemic stroke in the rat: reproducible extensive cortical infarction. Stroke. 1986 Jul-Aug; 17(4):738-43.
    View in: PubMed
    Score: 0.009
  23. Calcium-stimulated proteolysis in myelin: evidence for a Ca2+-activated neutral proteinase associated with purified myelin of rat CNS. J Neurochem. 1985 Aug; 45(2):581-8.
    View in: PubMed
    Score: 0.009
  24. Higher calpastatin levels correlate with resistance to calpain-mediated proteolysis and neuronal apoptosis in juvenile rats after spinal cord injury. J Neurotrauma. 2004 Sep; 21(9):1240-54.
    View in: PubMed
    Score: 0.008
  25. Tissue calcium levels in CaCl2-induced myelopathy. Neurosci Lett. 1984 Aug 31; 49(3):279-83.
    View in: PubMed
    Score: 0.008
  26. Relatively low levels of calpain expression in juvenile rat correlate with less neuronal apoptosis after spinal cord injury. Exp Neurol. 2004 Jun; 187(2):529-32.
    View in: PubMed
    Score: 0.008
  27. Early induction of secondary injury factors causing activation of calpain and mitochondria-mediated neuronal apoptosis following spinal cord injury in rats. J Neurosci Res. 2003 Jul 01; 73(1):95-104.
    View in: PubMed
    Score: 0.007
  28. Cell death in spinal cord injury (SCI) requires de novo protein synthesis. Calpain inhibitor E-64-d provides neuroprotection in SCI lesion and penumbra. Ann N Y Acad Sci. 2001 Jun; 939:436-49.
    View in: PubMed
    Score: 0.006
  29. Increased calpain expression is associated with apoptosis in rat spinal cord injury: calpain inhibitor provides neuroprotection. Neurochem Res. 2000 Oct; 25(9-10):1191-8.
    View in: PubMed
    Score: 0.006
  30. Calpain activity and expression increased in activated glial and inflammatory cells in penumbra of spinal cord injury lesion. J Neurosci Res. 2000 Jul 15; 61(2):146-50.
    View in: PubMed
    Score: 0.006
  31. Combined TUNEL and double immunofluorescent labeling for detection of apoptotic mononuclear phagocytes in autoimmune demyelinating disease. Brain Res Brain Res Protoc. 2000 Jul; 5(3):305-11.
    View in: PubMed
    Score: 0.006
  32. E-64-d prevents both calpain upregulation and apoptosis in the lesion and penumbra following spinal cord injury in rats. Brain Res. 2000 Jun 09; 867(1-2):80-9.
    View in: PubMed
    Score: 0.006
  33. The effects of spinal cord trauma on myelin. J Neuropathol Exp Neurol. 1980 May; 39(3):232-44.
    View in: PubMed
    Score: 0.006
  34. Characterization of the basic proteins from rodent peripheral nervous system myelin. J Neurochem. 1980 Feb; 34(2):453-5.
    View in: PubMed
    Score: 0.006
  35. Oxidative stress and Ca2+ influx upregulate calpain and induce apoptosis in PC12 cells. Brain Res. 2000 Jan 10; 852(2):326-34.
    View in: PubMed
    Score: 0.006
  36. Diverse stimuli induce calpain overexpression and apoptosis in C6 glioma cells. Brain Res. 1999 May 22; 829(1-2):18-27.
    View in: PubMed
    Score: 0.006
  37. Calpain activity and translational expression increased in spinal cord injury. Brain Res. 1999 Jan 23; 816(2):375-80.
    View in: PubMed
    Score: 0.005
  38. Calpeptin and methylprednisolone inhibit apoptosis in rat spinal cord injury. Ann N Y Acad Sci. 1999; 890:261-9.
    View in: PubMed
    Score: 0.005
  39. Increased calpain expression in activated glial and inflammatory cells in experimental allergic encephalomyelitis. Proc Natl Acad Sci U S A. 1998 May 12; 95(10):5768-72.
    View in: PubMed
    Score: 0.005
  40. Activation of JNK/SAPK in primary glial cultures: II. Differential activation of kinase isoforms corresponds to their differential expression. Neurochem Res. 1998 Feb; 23(2):219-25.
    View in: PubMed
    Score: 0.005
  41. New inhibitors of calpain prevent degradation of cytoskeletal and myelin proteins in spinal cord in vitro. J Neurosci Res. 1998 Jan 15; 51(2):218-22.
    View in: PubMed
    Score: 0.005
  42. Stage-specific expression of fuco-neolacto- (Lewis X) and ganglio-series neutral glycosphingolipids during brain development: characterization of Lewis X and related glycosphingolipids in bovine, human and rat brain. Glycoconj J. 1996 Jun; 13(3):367-75.
    View in: PubMed
    Score: 0.005
  43. Undernutrition in the developing rat: effect upon myelination. Brain Res. 1976 May 07; 107(2):239-55.
    View in: PubMed
    Score: 0.005
  44. Role of calpain in spinal cord injury: increased calpain immunoreactivity in rat spinal cord after impact trauma. Neurochem Res. 1996 Apr; 21(4):441-8.
    View in: PubMed
    Score: 0.004
  45. Chemical and immunological characterization of galactosyl-beta 1-3-globoside in bovine, human, and rat brain. J Neurochem. 1995 Nov; 65(5):2344-9.
    View in: PubMed
    Score: 0.004
  46. Calpain secreted by activated human lymphoid cells degrades myelin. J Neurosci Res. 1995 Oct 01; 42(2):259-65.
    View in: PubMed
    Score: 0.004
  47. Role of calpain in spinal cord injury: increased mcalpain immunoreactivity in spinal cord after compression injury in the rat. Neurochem Int. 1995 Oct-Nov; 27(4-5):425-32.
    View in: PubMed
    Score: 0.004
  48. Lead encephalopathy in the developing rat: effect on cortical ontogenesis. J Neuropathol Exp Neurol. 1974 Oct; 33(5):671-86.
    View in: PubMed
    Score: 0.004
  49. Effect of lead intoxication on the postnatal growth of the rat nervous system. Environ Health Perspect. 1974 May; 7:187-99.
    View in: PubMed
    Score: 0.004
  50. Lead encephalopathy in the developing rat: effect upon myelination. J Neuropathol Exp Neurol. 1974 Jan; 33(1):58-73.
    View in: PubMed
    Score: 0.004
  51. Effect of U-50488h, a selective opioid kappa receptor agonist, on vascular injury after spinal cord trauma. Brain Res. 1993 Oct 29; 626(1-2):45-9.
    View in: PubMed
    Score: 0.004
  52. Protective effect of methylprednisolone on vascular injury in rat spinal cord injury. J Neurotrauma. 1992; 9(3):245-53.
    View in: PubMed
    Score: 0.003
  53. Kininogen and kinin in experimental spinal cord injury. J Neurochem. 1991 Sep; 57(3):975-80.
    View in: PubMed
    Score: 0.003
  54. Differential regulation of myelin gene expression in SV40 T antigen-transfected rat glioma C6 cells. Metab Brain Dis. 1991 Mar; 6(1):7-17.
    View in: PubMed
    Score: 0.003
  55. Xanthine oxidase in experimental spinal cord injury. J Neurotrauma. 1991; 8(1):11-8.
    View in: PubMed
    Score: 0.003
  56. Leukotriene B4 release and polymorphonuclear cell infiltration in spinal cord injury. J Neurochem. 1990 Sep; 55(3):907-12.
    View in: PubMed
    Score: 0.003
  57. Polyethylene glycol-conjugated superoxide dismutase and catalase reduce ischemic brain injury. Am J Physiol. 1989 Feb; 256(2 Pt 2):H589-93.
    View in: PubMed
    Score: 0.003
  58. Arachidonic acid and its metabolites in cerebral ischemia. Ann N Y Acad Sci. 1989; 559:282-95.
    View in: PubMed
    Score: 0.003
  59. Calcium-activated neutral proteinase in rat brain myelin and subcellular fractions. J Neurosci Res. 1988 Jul; 20(3):351-8.
    View in: PubMed
    Score: 0.003
  60. Temporal profile of thromboxane-prostacyclin imbalance in experimental spinal cord injury. J Neurol Sci. 1988 Jan; 83(1):55-62.
    View in: PubMed
    Score: 0.003
  61. Brain calcium content in ischemic infarction. Neurology. 1987 Jul; 37(7):1227-9.
    View in: PubMed
    Score: 0.002
  62. Therapeutic model for experimental spinal cord injury in the rat: I. Mortality and motor deficit. Cent Nerv Syst Trauma. 1987; 4(3):149-59.
    View in: PubMed
    Score: 0.002
  63. Increased thromboxane level in experimental spinal cord injury. J Neurol Sci. 1986 Jul; 74(2-3):289-96.
    View in: PubMed
    Score: 0.002
  64. Proteolytic enzymes in experimental spinal cord injury. J Neurol Sci. 1986 May; 73(3):245-56.
    View in: PubMed
    Score: 0.002
  65. Vascular permeability in experimental spinal cord injury. J Neurol Sci. 1985 Oct; 70(3):275-82.
    View in: PubMed
    Score: 0.002
  66. Molecular and anatomical correlates of spinal cord injury. Cent Nerv Syst Trauma. 1985; 2(2):99-107.
    View in: PubMed
    Score: 0.002
  67. Changes in myelin and axonal proteins in CaCl2-induced myelopathy in rat spinal cord. Cent Nerv Syst Trauma. 1984; 1(2):131-7.
    View in: PubMed
    Score: 0.002
  68. Degradation of cytoskeletal proteins in experimental spinal cord injury. Neurochem Res. 1982 Dec; 7(12):1465-75.
    View in: PubMed
    Score: 0.002
  69. Basic proteins of rodent peripheral nerve myelin: immunochemical identification of the 21.5K, 18.5K, 17K, 14K, and P2 proteins. J Neurochem. 1982 Nov; 39(5):1278-82.
    View in: PubMed
    Score: 0.002
  70. Ca2+-accumulation in experimental spinal cord trauma. Brain Res. 1981 May 04; 211(2):476-9.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.